Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles

International Journal of Oncology (2013) - Comments
pubmed: 23835698 doi: 10.3892/ijo.2013.2008 issn: 1791-2423

Philippe G Aftimos, Murielle Wiedig, Mireille Langouo Fontsa, Ahmad Awada, Ghanem Ghanem, Fabrice Journe